| Trial of Tirzepatide for the Treatment of Cannabis Use Disorder (NCT07468552) | National Institute on Drug Abuse (NIDA) | 2026-11-15 |
| Phase 1 Study of Oral MG001 (NCT07204171) | National Institute on Drug Abuse (NIDA) | 2026-09-01 |
| Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl (NCT06995885) | National Institute on Drug Abuse (NIDA) | 2026-08-26 |
| Olfactory Function and Model-Based Behavior in People Living With HIV and SUD (NCT07637669) | National Institute on Drug Abuse (NIDA) | 2026-08-26 |
| SMART-r: Substance Monitoring and Active Relapse Tracking Repository (NCT06676059) | National Institute on Drug Abuse (NIDA) | 2026-08-26 |
| Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making (NCT06561828) | National Institute on Drug Abuse (NIDA) | 2026-08-26 |
| Environment and Alcohol: A Pilot Study (NCT06860607) | National Institute on Drug Abuse (NIDA) | 2026-08-26 |
| Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder (NCT06577454) | National Institute on Drug Abuse (NIDA) | 2026-08-26 |
| Phase I Trial of High-Density Theta Burst Stimulation (hdTBS) (NCT06868914) | National Institute on Drug Abuse (NIDA) | 2026-08-26 |
| Causal Mechanisms of Odor-Guided Behavior in Humans (NCT07099092) | National Institute on Drug Abuse (NIDA) | 2026-08-26 |
| VK4-116 Phase I Study With Food-Effect (NCT06808932) | National Institute on Drug Abuse (NIDA) | 2026-08-01 |
| Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot Study (NCT06503159) | National Institute on Drug Abuse (NIDA) | 2025-05-07 |
| SXC-2023 Cocaine Interaction Study (NCT06343532) | National Institute on Drug Abuse (NIDA) | 2024-10-08 |
| Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP (NCT06552741) | National Institute on Drug Abuse (NIDA) | 2024-09-04 |
| Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder (NCT06233799) | National Institute on Drug Abuse (NIDA) | 2024-07-01 |
| Semaglutide Therapy for Alcohol Reduction (STAR) (NCT06015893) | National Institute on Drug Abuse (NIDA) | 2023-10-17 |
| Spironolactone in Alcohol Use Disorder (SAUD) (NCT05807139) | National Institute on Drug Abuse (NIDA) | 2023-07-13 |
| Development and Validation of Learning and Decision-Making Tasks (NCT05707806) | National Institute on Drug Abuse (NIDA) | 2023-03-29 |
| Adolescent Vaping Characterization and Parent Views on Adolescent Vaping Protocol (NCT05669716) | National Institute on Drug Abuse (NIDA) | 2023-03-09 |
| Orexin s Role in the Neurobiology of Substance Use Disorder (NCT05630781) | National Institute on Drug Abuse (NIDA) | 2023-02-15 |
| Defining Neurobiological Links Between Substance Use and Mental Illness (NCT05538910) | National Institute on Drug Abuse (NIDA) | 2023-02-02 |
| Real-world Momentary Assessment of Kratom Use Accompanied by Product Assays: A Natural-history Study for Interdisciplinary Characterization of Kratom Use and Pharmacology (NCT05457803) | National Institute on Drug Abuse (NIDA) | 2022-07-20 |
| Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD (NCT04316559) | National Institute on Drug Abuse (NIDA) | 2021-12-27 |
| Evaluation of the Interactions of Cannabidiol (CBD) With Morphine (NCT05143424) | National Institute on Drug Abuse (NIDA) | 2021-11-04 |
| Manipulating Ghrelin Signaling Via GOAT Inhibition in Alcohol Use Disorder (NCT03896516) | National Institute on Drug Abuse (NIDA) | 2021-06-22 |
| Just-In-Time Adaptive Interventions for Addictive Behaviors (NCT03538652) | National Institute on Drug Abuse (NIDA) | 2020-02-19 |
| Imaging Biomarker for Addiction Treatment Outcome (NCT03427424) | National Institute on Drug Abuse (NIDA) | 2019-07-10 |
| Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder (NCT03745339) | National Institute on Drug Abuse (NIDA) | 2019-06-07 |
| State and Trait Mediated Response to TMS in Substance Use Disorder (NCT03707600) | National Institute on Drug Abuse (NIDA) | 2018-09-27 |
| Mechanism of Non-invasive Magnetic Stimulation (NCT03394066) | National Institute on Drug Abuse (NIDA) | 2018-09-19 |
| Comparison of Naloxone Pharmacokinetics (NCT03386591) | National Institute on Drug Abuse (NIDA) | 2018-01-03 |
| Lorcaserin in the Treatment of Cocaine Use Disorder (NCT03007394) | National Institute on Drug Abuse (NIDA) | 2017-12-19 |
| Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam (NCT03398083) | National Institute on Drug Abuse (NIDA) | 2017-12-04 |
| Exploring Gut-Brain and Brain-Gut Interactions in Alcohol Use Disorder Via Microbiota Investigations: A Pilot Study (NCT03152760) | National Institute on Drug Abuse (NIDA) | 2017-08-28 |
| Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers (NCT03129347) | National Institute on Drug Abuse (NIDA) | 2017-06-01 |
| Effects of a New Behavioral Intervention on Alcohol Craving and Drinking (NCT02831049) | National Institute on Drug Abuse (NIDA) | 2017-05-05 |
| Theta-Burst Stimulation as a Treatment for Reducing Cocaine Use (NCT02927236) | National Institute on Drug Abuse (NIDA) | 2017-02-13 |
| Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers (NCT02750748) | National Institute on Drug Abuse (NIDA) | 2016-07-01 |
| Evaluation of Intranasal Naltrexone and Naloxone (NCT03851731) | National Institute on Drug Abuse (NIDA) | 2015-10-05 |
| The Study of AZD8529 for Smoking Cessation in Female Smokers (NCT02401022) | National Institute on Drug Abuse (NIDA) | 2015-07-01 |
| Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin (NCT02393599) | National Institute on Drug Abuse (NIDA) | 2015-05-01 |
| Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers (NCT02572089) | National Institute on Drug Abuse (NIDA) | 2014-10-01 |
| Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study (NCT02231892) | National Institute on Drug Abuse (NIDA) | 2014-09-03 |
| Impact of Delta Opioid Receptor Gene (OPRD1) Variations on Treatment Outcome in African Americans (NCT02225184) | National Institute on Drug Abuse (NIDA) | 2014-08-23 |
| Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics (NCT02177513) | National Institute on Drug Abuse (NIDA) | 2014-06-14 |
| Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverity (NCT01867411) | National Institute on Drug Abuse (NIDA) | 2013-11-06 |
| Brain Networks and Addiction Susceptibility (NCT01924468) | National Institute on Drug Abuse (NIDA) | 2013-08-14 |
| Nicotine Withdrawal Symptoms and Smoking Relapse (NCT01511614) | National Institute on Drug Abuse (NIDA) | 2013-05-20 |
| Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana (NCT01844687) | National Institute on Drug Abuse (NIDA) | 2013-05-01 |
| Tobacco Cessation: Treatment Delivery and Predictors of Outcome (NCT01859364) | National Institute on Drug Abuse (NIDA) | 2013-04-27 |
| A Multi-Center Trial of Nepicastat for Cocaine Dependence (NCT01704196) | National Institute on Drug Abuse (NIDA) | 2013-04-01 |
| Three Strategies for Implementing Motivational Interviewing on Medical Inpatient Units (NCT01825057) | National Institute on Drug Abuse (NIDA) | 2013-02-21 |
| Interactions Between Intravenous Cocaine and Acetazolamide or Quinine (NCT01851473) | National Institute on Drug Abuse (NIDA) | 2012-10-24 |
| Studying Nicotine Addiction With Transcranial Magnetic Stimulation (NCT01702948) | National Institute on Drug Abuse (NIDA) | 2012-09-10 |
| Understanding Drug Abuse Treatment Outcomes (NCT01678833) | National Institute on Drug Abuse (NIDA) | 2012-07-19 |
| Factors Affecting Methamphetamine and Opiates Drug Testing (NCT01736332) | National Institute on Drug Abuse (NIDA) | 2012-07-19 |
| Health Outcomes by Neighborhood - Baltimore (NCT01571752) | National Institute on Drug Abuse (NIDA) | 2012-07-17 |
| Individual Differences in Reward and Impulse Control (NCT01621607) | National Institute on Drug Abuse (NIDA) | 2012-06-08 |
| Pexacerfont for Stress-induced Food Craving (NCT01656577) | National Institute on Drug Abuse (NIDA) | 2012-06-01 |
| Pexacerfont to Reduce Stress-induced Tobacco Craving (NCT01557556) | National Institute on Drug Abuse (NIDA) | 2012-02-24 |
| Stem Cell Study of Genetics and Drug Addiction (NCT01534624) | National Institute on Drug Abuse (NIDA) | 2012-02-07 |
| Pioglitazone to Treat Opioid Withdrawal Symptoms (NCT01517165) | National Institute on Drug Abuse (NIDA) | 2012-01-04 |
| Teenagers, Drug Addiction, and Reward and Impulse Control (NCT01443949) | National Institute on Drug Abuse (NIDA) | 2011-09-11 |
| Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study (NCT01359930) | National Institute on Drug Abuse (NIDA) | 2011-08-01 |
| Brain Functions Underlying Visuospatial Attention Deficits in Schizophrenia (NCT01399437) | National Institute on Drug Abuse (NIDA) | 2011-07-03 |
| Brain Circuits in Schizophrenia and Smoking (NCT01369966) | National Institute on Drug Abuse (NIDA) | 2011-05-16 |
| Neutral Correlates of Risk-taking in Adolescents Exposed to Drugs Prenatally (NCT01365988) | National Institute on Drug Abuse (NIDA) | 2011-05-15 |
| Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment (NCT01309685) | National Institute on Drug Abuse (NIDA) | 2011-02-13 |
| Characterization of Phenotypic and Genotypic Regressors for Imaging (NCT01148381) | National Institute on Drug Abuse (NIDA) | 2010-11-18 |
| Nicotinic Receptor Density in Smoking and Nonsmoking Schizophrenics (NCT01246128) | National Institute on Drug Abuse (NIDA) | 2010-10-31 |
| Nicotinic Modulation of the Default Network of Resting Brain Function (NCT01240616) | National Institute on Drug Abuse (NIDA) | 2010-10-24 |
| Pilot Study of Repetitive Transcranial Magnetic Stimulation in Cocaine Craving (NCT01222806) | National Institute on Drug Abuse (NIDA) | 2010-10-11 |
| Automated Prize-based Contingency Management to Increase Counseling Attendance in Opiate-Replacement-Therapy Patients (NCT01229163) | National Institute on Drug Abuse (NIDA) | 2010-10-03 |
| Effects of Antipsychotics on Eating and Food Craving in People With Schizophrenia (NCT01222793) | National Institute on Drug Abuse (NIDA) | 2010-09-26 |
| Assessment of Cannabis Craving in Schizophrenia Using Virtual Reality (NCT01212081) | National Institute on Drug Abuse (NIDA) | 2010-09-26 |
| Interactions Between Intravenous (IV) Cocaine and Lofexidine (NCT01148992) | National Institute on Drug Abuse (NIDA) | 2010-08-01 |
| The Effects of Expectation on Natural and Drug -Induced Rewards (NCT01036230) | National Institute on Drug Abuse (NIDA) | 2010-05-24 |
| Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms (NCT01505725) | National Institute on Drug Abuse (NIDA) | 2010-03-16 |
| Oral Fluid, Plasma and Whole Pharmacokinetics and Stability Following Smoked Cannabis (NCT01071616) | National Institute on Drug Abuse (NIDA) | 2010-01-22 |
| Assessing Top Down and Bottom Up Attention Mechanisms in Smokers Using Nicotine Nasal Spray (NCT01136642) | National Institute on Drug Abuse (NIDA) | 2010-01-21 |
| Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults (NCT01046539) | National Institute on Drug Abuse (NIDA) | 2010-01-01 |
| Measuring Distress Tolerance With Functional MRI (NCT01038232) | National Institute on Drug Abuse (NIDA) | 2009-12-04 |
| Human Factors Analysis in VR for Burn Treatment (NCT00409552) | National Institute on Drug Abuse (NIDA) | 2009-11-01 |
| Prenatal Drug Exposure: Effects on the Adolescent Brain and Behavior Development (NCT01020669) | National Institute on Drug Abuse (NIDA) | 2009-10-16 |
| Pilot Study Repetitive Transcranial Magnetic Stimulation (rTMS) in Cannabis Craving (NCT01031290) | National Institute on Drug Abuse (NIDA) | 2009-08-19 |
| Risk Perception in Drug-Dependent Adults With and Without Schizophrenia (NCT01031563) | National Institute on Drug Abuse (NIDA) | 2009-08-18 |
| Assessment of Craving in Nicotine-Dependent Patients With Schizophrenia Using Virtual Reality (NCT01031433) | National Institute on Drug Abuse (NIDA) | 2009-07-28 |
| Brain Glutamate Receptors and Cocaine Dependence (NCT00951314) | National Institute on Drug Abuse (NIDA) | 2009-07-14 |
| Developing Field Tools for Real-Time Assessment of Exposure to Psychosocial Stress and Drug Use in an Outpatient Treatment Population (NCT00787423) | National Institute on Drug Abuse (NIDA) | 2009-07-14 |
| Pilot Study of Transcranial Magnetic Stimulation (TMS) in Nicotine Addiction (NCT01031693) | National Institute on Drug Abuse (NIDA) | 2009-07-13 |
| Reinforcement-Based Treatment for Pregnant Drug Abusers (NCT01177982) | National Institute on Drug Abuse (NIDA) | 2009-07-01 |
| Breath Carbon Monoxide and Cotinine as Biomarkers to Distinguish Smokers From Nonsmokers (NCT01031121) | National Institute on Drug Abuse (NIDA) | 2009-06-08 |
| Effects of Nicotine on Areas of Impaired and Preserved Functioning in Schizophrenia (NCT01034085) | National Institute on Drug Abuse (NIDA) | 2009-06-02 |
| Screening Protocol for the Evaluation of Research Participants at the Maryland Psychiatric Research Center (MPRC) (NCT01030835) | National Institute on Drug Abuse (NIDA) | 2009-05-28 |
| Sublingual Buprenorphine for Chronic Pain (NCT00612287) | National Institute on Drug Abuse (NIDA) | 2009-04-01 |
| Effectiveness of Motivational Interviewing Supervision in Community Programs (NCT01586676) | National Institute on Drug Abuse (NIDA) | 2009-01-01 |
| A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive Control (NCT00830739) | National Institute on Drug Abuse (NIDA) | 2008-11-25 |
| Oxytocin and Cognitive Behavioral Therapy in Drug Dependence (NCT00975416) | National Institute on Drug Abuse (NIDA) | 2008-11-01 |
| Individual and Group Intervention Formats With Aggressive Children (NCT01710969) | National Institute on Drug Abuse (NIDA) | 2008-09-01 |
| Buprenorphine Naltrexone-P1 A-Cocaine (NCT00733720) | National Institute on Drug Abuse (NIDA) | 2008-08-01 |